Other compounds include Andrographolide (89, 90) and Parthenolide (96), which mainly target NF-κB signaling pathway, but the later was also shown to directly inhibit NLRP3 inflammasome by interfering with its ATPase activity (128), have also shown promising results in several cancers (129). The gene discussed is NLRP3; the disease is cancer.